| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $3.22B | +8.2% |
| Cost of Revenue | $663.1M | +6.7% |
| Gross Profit | $2.56B | +8.5% |
| R&D Expense | $665.0M | +13.0% |
| SG&A Expense | $389.0M | +3.5% |
| Operating Income | $298.6M | +49.3% |
| Pre-tax Income | $347.3M | +40.1% |
| Income Tax | $38.2M | +104.7% |
| Net Income | $309.1M | -71.1% |
| EPS (Basic) | $1.53 | -70.7% |
| EPS (Diluted) | $1.48 | -70.9% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $602.4M | -7.1% |
| Accounts Receivable | $516.4M | +20.2% |
| Current Assets | $1.49B | +0.1% |
| Total Assets | $4.23B | +5.4% |
| Current Liabilities | $2.04B | +11.3% |
| Total Liabilities | $2.31B | +15.0% |
| Stockholders' Equity | $1.92B | -4.2% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.17B | +14.5% |
| Capital Expenditures | $106.4M | +9.8% |
| Investing Cash Flow | -$126.8M | +59.5% |
| Financing Cash Flow | -$1.10B | -31.1% |
| Free Cash Flow | $1.06B | +15.0% |